ActivePure Medical Technology to Present Hospital Infection Control Data at IDWeek 2024

DALLAS--(BUSINESS WIRE)--ActivePure Medical, a division of AP Sciences Group, LLC, a global provider of cutting-edge, continuous air and surface decontamination technology for healthcare, today announced it will present two posters demonstrating the efficacy of its ActivePure Technology in reducing microbial contamination in healthcare settings at IDWeek 2024, taking place October 16-19, 2024, in Los Angeles.

Details of the poster presentations are as follows:

Abstract ID: P-356
Title: Reduction of high-touch surface aerobic bacteria and fungi colony counts with the implementation of ActivePure continuous disinfection technology
Presented by: Denise Taylor, RN, BSN, CIC, Infection Control Director at Ochsner LSU Health Shreveport, in collaboration with ActivePure Medical
Date/Time: Thursday, October 17, 2024, 12:15-1:30 PM PT

Abstract ID: P-1848
Title: Reduction of microbial burden on environmental floor samples through advanced photohydrolysis technology and its impact on Candida auris, fungi, and aerobic bacteria
Presented by: Kimberly Trosch, RN, BSN, Director of Clinical Affairs at ActivePure Medical, in collaboration with Sinai Hospital of Baltimore, part of LifeBridge Health
Date/Time: Saturday, October 19, 2024, 12:15-1:30 PM PT

About ActivePure Medical

ActivePure Medical, a division of AP Sciences Group, LLC, is a global leader in proactive, continuous surface and air decontamination systems for healthcare. The company's proprietary ActivePure Advanced Photohydrolysis Technology safely neutralizes indoor contaminants in the air and on surfaces. This scientifically adapted technology replicates the natural atmospheric cleansing processes, providing continuous, persistent protection against environmental contamination risks without relying on human intervention. ActivePure Technology effectively reduces many common volatile organic compounds (VOCs) and operates without producing harmful ozone, making it safe for continuous use in occupied spaces. Initially developed for space exploration, it has evolved to reduce exposure to pathogens, including RNA and DNA viruses, bacteria, and molds, by up to 99.9% in the air and on surfaces. ActivePure Technology has proven effective across various settings, including acute care, long-term care facilities, and commercial buildings. ActivePure Technology is a key component in the ActivePure Medical Guardian, an FDA 510(k)-cleared Class II Medical Device. For more information, please visit ActivePure.com/healthcare.